Cargando…

The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome

AIM: To evaluate the association between the apolipoprotein B/A1 ratio (ApoB/ApoA1) and metabolic and endocrine parameters in women with polycystic ovary syndrome (PCOS). METHODS: This study was a secondary analysis of the Acupuncture and Clomiphene for Chinese Women with Polycystic Ovary Syndrome t...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Hui, Feng, Jiaxing, Zhang, Shike, Wang, Yu, Li, Jian, Gao, Jingshu, Cong, Jing, Gong, Yi, Wu, Xiaoke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766308/
https://www.ncbi.nlm.nih.gov/pubmed/35069437
http://dx.doi.org/10.3389/fendo.2021.773781
_version_ 1784634501600641024
author He, Hui
Feng, Jiaxing
Zhang, Shike
Wang, Yu
Li, Jian
Gao, Jingshu
Cong, Jing
Gong, Yi
Wu, Xiaoke
author_facet He, Hui
Feng, Jiaxing
Zhang, Shike
Wang, Yu
Li, Jian
Gao, Jingshu
Cong, Jing
Gong, Yi
Wu, Xiaoke
author_sort He, Hui
collection PubMed
description AIM: To evaluate the association between the apolipoprotein B/A1 ratio (ApoB/ApoA1) and metabolic and endocrine parameters in women with polycystic ovary syndrome (PCOS). METHODS: This study was a secondary analysis of the Acupuncture and Clomiphene for Chinese Women with Polycystic Ovary Syndrome trial (PCOSAct), and 957 subjects with available ApoB and ApoA1 measurements were included. Tests for linear trends and linear regression were used to assess the relation between the ApoB/ApoA1 ratio and metabolic and endocrine parameters. Logistic regression was used to estimate the association between the ratio and risk of metabolic syndrome (MetS) and insulin resistance (IR). The receiver operating characteristics (ROC) curve was used to determine the predictive value of the ApoB/ApoA1 ratio for MetS and IR. RESULTS: The results showed that the ApoB/ApoA1 ratio was positively associated with waist circumference, systolic blood pressure, total cholesterol, triglycerides, low-density lipoprotein, fasting plasma glucose, fasting insulin, homeostatic model assessment-insulin resistance, high free testosterone, high free androgen index, alanine transferase, aspartate transferase, and higher prevalence of MetS and IR, but was negatively correlated with high-density lipoprotein and sex hormone-binding globulin after adjusting for age and body mass index. Logistic regression showed that compared with the ApoB/ApoA1 ratio in first quartile, those in the fourth quartile demonstrated a higher risk of MetS (OR: 24.48, 95%CI: 8.54–70.15, P trend <0.001) and IR (OR: 1.78, 95%CI: 1.10–2.87, P trend <0.05) after adjusting for confounding factors. ROC curve results showed that the AUC(MetS) was 0.84 (95%CI: 0.81–0.86) and had 86.8% sensitivity and 70.3% specificity with a threshold value of 0.64, and the AUC(IR) was 0.68 (95%CI: 0.64–0.71) and had 74.3% sensitivity and 58.2% specificity with a threshold value of 0.56. CONCLUSIONS: Increased ApoB/ApoA1 ratio was associated with worse MetS components, IR, and elevated androgen hormones and liver enzymes. The ratio might be a useful tool to screen for MetS and IR in PCOS patients.
format Online
Article
Text
id pubmed-8766308
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87663082022-01-20 The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome He, Hui Feng, Jiaxing Zhang, Shike Wang, Yu Li, Jian Gao, Jingshu Cong, Jing Gong, Yi Wu, Xiaoke Front Endocrinol (Lausanne) Endocrinology AIM: To evaluate the association between the apolipoprotein B/A1 ratio (ApoB/ApoA1) and metabolic and endocrine parameters in women with polycystic ovary syndrome (PCOS). METHODS: This study was a secondary analysis of the Acupuncture and Clomiphene for Chinese Women with Polycystic Ovary Syndrome trial (PCOSAct), and 957 subjects with available ApoB and ApoA1 measurements were included. Tests for linear trends and linear regression were used to assess the relation between the ApoB/ApoA1 ratio and metabolic and endocrine parameters. Logistic regression was used to estimate the association between the ratio and risk of metabolic syndrome (MetS) and insulin resistance (IR). The receiver operating characteristics (ROC) curve was used to determine the predictive value of the ApoB/ApoA1 ratio for MetS and IR. RESULTS: The results showed that the ApoB/ApoA1 ratio was positively associated with waist circumference, systolic blood pressure, total cholesterol, triglycerides, low-density lipoprotein, fasting plasma glucose, fasting insulin, homeostatic model assessment-insulin resistance, high free testosterone, high free androgen index, alanine transferase, aspartate transferase, and higher prevalence of MetS and IR, but was negatively correlated with high-density lipoprotein and sex hormone-binding globulin after adjusting for age and body mass index. Logistic regression showed that compared with the ApoB/ApoA1 ratio in first quartile, those in the fourth quartile demonstrated a higher risk of MetS (OR: 24.48, 95%CI: 8.54–70.15, P trend <0.001) and IR (OR: 1.78, 95%CI: 1.10–2.87, P trend <0.05) after adjusting for confounding factors. ROC curve results showed that the AUC(MetS) was 0.84 (95%CI: 0.81–0.86) and had 86.8% sensitivity and 70.3% specificity with a threshold value of 0.64, and the AUC(IR) was 0.68 (95%CI: 0.64–0.71) and had 74.3% sensitivity and 58.2% specificity with a threshold value of 0.56. CONCLUSIONS: Increased ApoB/ApoA1 ratio was associated with worse MetS components, IR, and elevated androgen hormones and liver enzymes. The ratio might be a useful tool to screen for MetS and IR in PCOS patients. Frontiers Media S.A. 2022-01-05 /pmc/articles/PMC8766308/ /pubmed/35069437 http://dx.doi.org/10.3389/fendo.2021.773781 Text en Copyright © 2022 He, Feng, Zhang, Wang, Li, Gao, Cong, Gong and Wu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
He, Hui
Feng, Jiaxing
Zhang, Shike
Wang, Yu
Li, Jian
Gao, Jingshu
Cong, Jing
Gong, Yi
Wu, Xiaoke
The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome
title The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome
title_full The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome
title_fullStr The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome
title_full_unstemmed The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome
title_short The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome
title_sort apolipoprotein b/a1 ratio is associated with metabolic syndrome components, insulin resistance, androgen hormones, and liver enzymes in women with polycystic ovary syndrome
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766308/
https://www.ncbi.nlm.nih.gov/pubmed/35069437
http://dx.doi.org/10.3389/fendo.2021.773781
work_keys_str_mv AT hehui theapolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT fengjiaxing theapolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT zhangshike theapolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT wangyu theapolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT lijian theapolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT gaojingshu theapolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT congjing theapolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT gongyi theapolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT wuxiaoke theapolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT hehui apolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT fengjiaxing apolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT zhangshike apolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT wangyu apolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT lijian apolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT gaojingshu apolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT congjing apolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT gongyi apolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome
AT wuxiaoke apolipoproteinba1ratioisassociatedwithmetabolicsyndromecomponentsinsulinresistanceandrogenhormonesandliverenzymesinwomenwithpolycysticovarysyndrome